Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julie M Crawford

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Nursing Education Perspectives|December 8, 2022
Utilizing a High-Fidelity COVID-19 Simulation to Develop Collaboration Skills Among Multispecialty CohortsJulie M Crawford, Ashley H Lee
Journal of Clinical Gastroenterology|June 3, 2024
Factors Predicting Loss of Remission in Crohn's Disease Patients in Endoscopic Remission in the Real World: Results From TARGET-IBDHarris Ahmad, Benjamin Click, Heather L Morris, et al.
Clinical and Translational Gastroenterology|July 14, 2023
Prevalence of Immunomodulator Use as Combination Therapy With Vedolizumab or Ustekinumab in Inflammatory Bowel DiseaseMegan Lutz, Freddy Caldera, Katie Schroeder, et al.
Hepatology Communications|May 16, 2018
A real-world observational cohort of patients with primary biliary cholangitis: TARGET-primary biliary cholangitis study design and rationaleCynthia Levy, Christopher L Bowlus, Elizabeth Carey, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 20, 2021
Factors Associated With Readmission in the United States Following Hospitalization With Coronavirus Disease 2019Elizabeth C Verna, Charles Landis, Robert S Brown, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 29, 2020
Patient Characteristics and Outcomes of 11 721 Patients With Coronavirus Disease 2019 (COVID-19) Hospitalized Across the United StatesMichael W Fried, Julie M Crawford, Andrea R Mospan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 21, 2020
Reply to Roussel et alMichael W Fried, Julie M Crawford, Andrea R Mospan, et al.
Epidemiology (Cambridge, Mass.)|January 31, 2023
Effectiveness of Remdesivir Treatment Protocols Among Patients Hospitalized with COVID-19: A Target Trial EmulationAlexander Breskin, Catherine Wiener, Adaora A Adimora, et al.
BMC Gastroenterology|February 20, 2022
Objective disease activity assessment and therapeutic drug monitoring prior to biologic therapy changes in routine inflammatory bowel disease clinical practice: TARGET-IBDBenjamin Click, Edward L Barnes, Benjamin L Cohen, et al.
The Journal of Dermatological Treatment|December 11, 2024
Real-world evidence on the benefits of optimal itch relief and skin clearance in atopic dermatitis management: a study from the TARGET-DERM AD registryJonathan I Silverberg, Brian M Calimlim, Ayman Grada, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Nursing Education Perspectives|December 8, 2022
Utilizing a High-Fidelity COVID-19 Simulation to Develop Collaboration Skills Among Multispecialty CohortsJulie M Crawford, Ashley H Lee
Journal of Clinical Gastroenterology|June 3, 2024
Factors Predicting Loss of Remission in Crohn's Disease Patients in Endoscopic Remission in the Real World: Results From TARGET-IBDHarris Ahmad, Benjamin Click, Heather L Morris, et al.
Clinical and Translational Gastroenterology|July 14, 2023
Prevalence of Immunomodulator Use as Combination Therapy With Vedolizumab or Ustekinumab in Inflammatory Bowel DiseaseMegan Lutz, Freddy Caldera, Katie Schroeder, et al.
Hepatology Communications|May 16, 2018
A real-world observational cohort of patients with primary biliary cholangitis: TARGET-primary biliary cholangitis study design and rationaleCynthia Levy, Christopher L Bowlus, Elizabeth Carey, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 20, 2021
Factors Associated With Readmission in the United States Following Hospitalization With Coronavirus Disease 2019Elizabeth C Verna, Charles Landis, Robert S Brown, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 29, 2020
Patient Characteristics and Outcomes of 11 721 Patients With Coronavirus Disease 2019 (COVID-19) Hospitalized Across the United StatesMichael W Fried, Julie M Crawford, Andrea R Mospan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 21, 2020
Reply to Roussel et alMichael W Fried, Julie M Crawford, Andrea R Mospan, et al.
Epidemiology (Cambridge, Mass.)|January 31, 2023
Effectiveness of Remdesivir Treatment Protocols Among Patients Hospitalized with COVID-19: A Target Trial EmulationAlexander Breskin, Catherine Wiener, Adaora A Adimora, et al.
BMC Gastroenterology|February 20, 2022
Objective disease activity assessment and therapeutic drug monitoring prior to biologic therapy changes in routine inflammatory bowel disease clinical practice: TARGET-IBDBenjamin Click, Edward L Barnes, Benjamin L Cohen, et al.
The Journal of Dermatological Treatment|December 11, 2024
Real-world evidence on the benefits of optimal itch relief and skin clearance in atopic dermatitis management: a study from the TARGET-DERM AD registryJonathan I Silverberg, Brian M Calimlim, Ayman Grada, et al.
Pageof 2